Drug Discovery & Trials

Targets, biomarkers, AI discovery, and Phases I–III clinical results.

  • 19 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Drug Discovery & Trials


news.iu.edu > it > live > news > 51128-accelerating-discovery-iu-researchers-optimize

Accelerating Discovery: IU researchers optimize AlphaFold3 for faster biological insights

12+ hour, 51+ min ago   (175+ words) For IU Bloomington biologist Ankur Dalia, AlphaFold3 predictions are not an end point. They help decide what to test next at the bench. The sooner those results arrive, the sooner his lab can turn a computational lead into a real experiment....


wfmz.com > news > pr_newswire > pr_newswire_health > stowers-scientist-selected-for-28-6-million-research-effort-to-predict-protein-changes-behind-neurodegenerative-disease > article_045fd8ce-b494-5da4-bdc3-a0d26c365780.html

Stowers scientist selected for $28.6 million research effort to predict protein changes behind neurodegenerative disease

3+ hour, 18+ min ago   (850+ words) Partly to mostly cloudy.. Halfmann will help decode the language of disordered proteins associated with neurodegenerative diseases by generating large-scale experimental data. Specifically, his lab will produce more than 10 billion measurements of aggregation, taken one living cell at a time,…...


pharmtech.com > view > q-a-patient-centric-drug-development-should-start-at-product-definition

Q&A: Patient-Centric Drug Development Should Start at Product Definition

1+ hour, 39+ min ago   (160+ words) For formulation and manufacturing teams, the challenge is translating those priorities into dosage-form, packaging, and supply decisions. Ahead of his presentation at CPHI Worldwide 2026 (Oct. 6–8, Milan), Ron Scarborough, CEO of Azurity Pharmaceuticals, discussed why nonadherence should be examined as a…...


en.sedaily.com > international > 10/10/2026 > zuckerberg-backed-biohub-joins-google-us-agencies-in-18

Zuckerberg-Backed Biohub Joins Google, U.S. Agencies in $1.8 Billion Virtual Cell Push

3+ hour, 39+ min ago   (331+ words) Google, Meta and U.S. Government to Build Data for "Virtual Cell" Research Partners to Produce and Standardize Data to Train AI Models Goal Is to Identify Most Promising Experiments Before Lab Work Begins One-Year Exclusive Access Offers Incentive for Corporate Funding…...


biospace.com > press-releases > seaport-therapeutics-presents-additional-pharmacokinetic-data-from-phase-1-clinical-trial-of-glyphago-at-the-39th-european-college-of-neuropsychopharmacology-ecnp-congress

Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress

10+ hour, 20+ min ago   (668+ words) BioSpace Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress First scientific presentation of detailed PK data demonstrates dose-dependent increases in agomelatine exposure, no food effect, and no accumulation…...


news-medical.net-medical.net

Tracking lipid metabolism with submicron IR

8+ hour, 55+ min ago   (471+ words) It is well documented that saturated fatty acids are more toxic than unsaturated ones. However, the underlying mechanism remains unresolved because it is extremely difficult to visualize the subcellular chemical conversions at the root of lipotoxicity, the lipid accumulation that…...


eurekalert.org > news-releases > 1147111

Stowers scientist selected for $28.6 million effort to predict protein changes behind neurodegenerative disease

8+ hour, 42+ min ago   (797+ words) The new award brings together a team of scientists who will combine AI, large-scale experiments and human-cell studies to predict harmful protein changes before disease takes hold. image: Randal Halfmann, Ph.D., Investigator at the Stowers Institute for Medical Research, studies…...


young.senate.gov > newsroom > press-releases > young-highlights-indianas-leadership-in-biotech-at-iu-symposium

Young Highlights Indiana’s Leadership in Biotech at IU Symposium

7+ hour, 38+ min ago   (236+ words) Senator Young (.gov) Young Highlights Indiana’s Leadership in Biotech at IU Symposium WASHINGTON – U.S. Senator Todd Young (R-Ind.) addressed Indiana University’s Biotechnology Symposium in Indianapolis on Thursday and highlighted Indiana’s growing role in the life sciences industry and the…...


wvnews.com > news > wvnews > greenbrier-valley-bio-hub-aims-to-expand-west-virginia-bioscience-sector > article_bc82c0a9-9bb9-4023-af7e-db132507a1db.html

Greenbrier Valley Bio Hub aims to expand West Virginia bioscience sector

5+ hour, 10+ min ago   (662+ words) The Greenbrier Valley Bio Hub at WVSOM is under construction in Lewisburg and is expected to expand research opportunities, attract biotechnology companies and support West Virginia’s bioscience economy. SNOWSHOE, W.Va. — Leaders from the West Virginia School of Osteopathic Medicine…...


drugdiscoverynews.com > technology-guide-high-content-analysis-in-modern-drug-discovery-17583

Technology Guide: High-content analysis in modern drug discovery

5+ hour, 59+ min ago   (149+ words) Drug Discovery News Technology Guide: High-content analysis in modern drug discovery As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery. As drug discovery increasingly relies on complex biological models, researchers need imaging…...